Fetal programming of children's obesity risk

Stephanie A Stout,Emma V Espel,Curt A Sandman,Laura M Glynn,Elysia Poggi Davis

doi:10.1016/j.psyneuen.2014.12.009

Stephanie A Stout, Emma V Espel + Show 3 more

Open Access

https://doi.org/10.1016/j.psyneuen.2014.12.009

Copy DOI

Abstract

Childhood obesity affects nearly 17% of children and adolescents in the United States. Increasing evidence indicates that prenatal maternal stress signals influence fetal growth, child obesity, and metabolic risk. Children exhibiting catch-up growth, a rapid and dramatic increase in body size, within the first two years of life are also at an increased risk for developing metabolic disorder and obesity. We evaluate the potential role of the maternal hypothalamic-pituitary-adrenal (HPA) and placental axis in programming risk for child obesity. This prospective longitudinal study measured placental corticotropin-releasing hormone (pCRH) and maternal plasma cortisol at 15, 19, 25, 30, and 37 gestational weeks and collected child body mass index (BMI) at birth, 3, 6, 12, and 24 months. Participants included 246 mothers and their healthy children born full term. Each child's BMI percentile (BMIP) was determined using World Health Organization (WHO) standards based on age and sex. Child BMIP profiles from birth to two years of age were characterized using general growth mixture modeling (GGMM). We evaluated whether fetal exposure to placental CRH and maternal cortisol are associated with BMIP profiles. Placental CRH at 30 gestational weeks was highly associated with both BMIP (p<.05) and weight (p<.05) at birth when accounting for gestational age at birth and used as a predictor in modeling BMIP profiles. Maternal cortisol was not associated with child BMIP. GGMM analyses identified four distinct BMIP profiles: typical, rapid increase, delayed increase, and decreasing (See Fig. 2). The typical profile comprised the majority of the sample and maintained BMIP across the first two years. The rapid and delayed increase profiles each exhibit a period of reduced body size followed by BMI catch-up growth. The rapid increase profile exhibited catch-up within the first 12 months while the delayed group showed an initial decrease in BMIP at 3 months and a dramatic increase from 12 to 24 months. The decreasing profile exhibited normal birth weight and BMIP followed by persisting, low BMIP. The members of the rapid and delayed increase profiles were exposed to the highest concentrations of placental CRH at 30 gestational weeks compared to those in the typical profile group (Fig. 3). Exposure to elevated placental CRH concentrations during the third trimester is associated with catch-up growth. An early period of small body size followed by rapid catch-up growth is a profile associated with increased metabolic risk and increased obesity risk. Our findings suggest that placental CRH exposure makes a unique contribution to fetal programming of obesity risk.

Highlights

Childhood obesity in the United States is a growing problem, affecting nearly 17% of children ages 2–19 (Ogden et al, 2012)
We evaluated whether fetal exposure to placental corticotropin-releasing hormone (CRH) and maternal cortisol are associated with BMI percentile (BMIP) profiles
Placental CRH at 30 gestational weeks was highly associated with both BMIP (p

Summary

Introduction

Childhood obesity in the United States is a growing problem, affecting nearly 17% of children ages 2–19 (Ogden et al, 2012). Increasing evidence suggests that exposure to stress and stress hormones during the fetal period have a long-term influence on metabolic health and obesity risk (Gangestad et al, 2012). The Fetal Programming (Barker, 1998) and Developmental Origins of Disease (Gluckman et al, 2008) models posit that during periods of rapid development, such as prenatal life and early infancy, the organism is susceptible to environmental factors that have a persisting influence on disease risk. Small size at birth is an indicator of exposure to prenatal perturbations, which affect physical development and metabolic function (Gangestad et al, 2012). Compelling evidence from epidemiological studies indicates that small size at birth is a risk factor for a range of metabolic problems including high adult body mass index (BMI), Psychoneuroendocrinology.

Methods

Results

Conclusion